Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance
Filings
30 filings of SIGNATURE since January 2025.
board outcome 10, presentation 8, transcript 8, results 2, credit rating 2
| Filed | Type | Subject | |
|---|---|---|---|
| 13 Nov 2026 | transcript Acquisition, Capex, Guidance, Rating, Results | Signatureglobal (India) Limited has informed the Exchange about TranscriptAI summarySignatureglobal (India) filed the transcript of its Q2 FY27 results investor/analyst call held on 6 November 2026. Management said H1 sales were about INR38 billion (about 675 units, 1.6 million sq ft), about 40% of the INR100 billion annual sales guidance, which management said is unchanged. Management said H1 collections were about INR17 billion, H1 cash surplus about INR4.8 billion, and expected INR12-15 billion by year end; net debt was about INR4.5 billion, gross debt INR28.7 billion, and CARE rating A+ with stable outlook. Management reported about 10 million sq ft of new developable area added in H1, H1 revenue recognition of about INR14 billion, gross margin about 31% for H1 (36% in Q2), EBITDA margin 13% for H1 (18% in Q2), and reiterated annual completions guidance of about INR50 billion. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Nov 2026 | presentation Capex, Guidance, Rating, Results | Signatureglobal (India) Limited has informed the Exchange about Investor PresentationAI summaryInvestor presentation for the H1 FY27 investor/analyst call on 6 November 2026 at 8:00 A.M. (IST), uploaded to the company website. H1 FY27 sales bookings were INR 38.0 bn (vs INR 46.6 bn in H1 FY26); Q2 FY27 sales were INR 18.3 bn (vs INR 20.2 bn in Q2 FY26). Over 675 units sold at an average ticket size of INR 55.9 mn in H1 FY27. H1 FY27 collections were INR 16.8 bn (vs INR 18.6 bn in H1 FY26); about 34% of the full-year collection guidance achieved. Operating cash surplus before land investment was INR 4.8 bn in H1 FY27; net debt was INR 4.5 bn as of 30 September 2026. CARE reaffirmed A+ (stable) rating on gross debt including NCDs. Management guided FY27 pre-sales of INR 100 bn, launches of INR 150 bn and collections of INR 50 bn, and said the full-year launch guidance remains on track with balance launches planned in H2 FY27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 05 Nov 2026 | board outcome Management change, Results | Signatureglobal (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.AI summaryBoard approved unaudited consolidated and standalone financial results for the quarter and half year ended 30 September 2026; consolidated revenue from operations for the quarter was Rs 8,174.09 million and net profit was Rs 669.05 million. Consolidated total income for the quarter was Rs 8,707.00 million, against Rs 3,725.13 million in the corresponding quarter last year; six-month consolidated net profit was Rs 503.76 million. Board re-appointed Pradeep Kumar Aggarwal (Chairman and Whole Time Director), Lalit Kumar Aggarwal (Vice Chairman and Whole Time Director), Ravi Aggarwal (Managing Director) and Devender Aggarwal (Joint Managing Director and Whole Time Director) for three years with effect from 15 February 2027, subject to member approval. Security Cover Certificate as at 30 September 2026 was enclosed. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 Sep 2026 | credit rating Rating | Signatureglobal (India) Limited has informed the Exchange about Credit RatingAI summarySIGNATUREGLOBAL (INDIA) LIMITED filed intimation under Regulations 30, 51 and 55 of SEBI Listing Regulations on credit ratings assigned by CARE Ratings Limited, communicated on 21 September 2026. CARE reaffirmed CARE A+; Stable on Non-Convertible Debentures of Rs. 719.17 crore and Rs. 10.00 crore. CARE assigned CARE A+; Stable to Long-Term Bank Facilities of Rs. 30.00 crore and reaffirmed CARE A+; Stable on Long-Term Bank Facilities of Rs. 2,753.00 crore. The rating review took into account the company's FY26 (audited) and Q1FY27 (unaudited) operational and financial performance. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 Aug 2026 | transcript Acquisition, Capex, Guidance, Results | Signatureglobal (India) Limited has informed the Exchange about TranscriptAI summarySignatureGlobal (India) filed the transcript of its Q1 FY27 earnings conference call held on 6 August 2026, hosted by ICICI Securities. Management said the Tonino Lamborghini branded residence project in Sector 71, Gurugram, was launched at a price a little above Rs. 22,000 per sq ft, with GDV in excess of Rs. 4,000 crores; about 800 units were offered, about 400 opened for the first phase and more than 300 sold. Management reiterated FY27 guidance of new launches worth Rs. 150 billion and pre-sales of about Rs. 100 billion, saying about Rs. 20 billion of pre-sales was achieved in Q1. Management expects to complete projects worth over Rs. 5,000 crores and recognise revenue of about Rs. 50 billion during the year, and said collections were Rs. 6.7 billion in the quarter. Management said it plans significant land business development, with land capex of about Rs. 1,500-1,800 crores for the year, and that net debt may rise modestly from the current level of less than Rs. 3.9 billion. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Aug 2026 | presentation Capex, Guidance, Results | Signatureglobal (India) Limited has informed the Exchange about Investor PresentationAI summaryInvestor presentation for Q1 FY27 (Aug 2026) filed ahead of the investors/analysts call on 6 August 2026 at 5:00 PM IST. Q1 FY27 sales were INR 19.7 bn versus INR 26.4 bn in Q1 FY26; management said this was driven by the launch of Tonino Lamborghini Residences, and sales are about 20% of the FY27 sales guidance. Q1 FY27 collections were INR 6.7 bn versus INR 9.3 bn in Q1 FY26; management expects collections to strengthen through the year. Average sales realization was about INR 17,093 per sq ft in Q1 FY27 versus about INR 15,250 per sq ft in FY26; cash and bank balances were INR 25.22 bn and net debt was INR 3.9 bn as of 30 June 2026. FY27 guidance shows pre-sales of INR 100 bn, launches of INR 150 bn, collections of INR 50 bn and revenue recognition of INR 50 bn, with management stating the pre-sales figure reflects sustaining last-year sales levels. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 06 Aug 2026 | board outcome Dividend / buy-back, Management change, Results | Signatureglobal (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.AI summaryBoard of SIGNATUREGLOBAL (INDIA) Limited approved unaudited consolidated and standalone results for the quarter ended 30 June 2026 on 6 August 2026. Consolidated revenue from operations for Q1 FY27 was Rs 5,519.89 million, against Rs 11,072.66 million in the year-ago quarter; net loss was Rs 165.29 million, against a net profit of Rs 11,524.08 million a year earlier, which included exceptional items of Rs 12,672.19 million. Basic loss per share for the quarter was Rs 1.18 (quarterly figures not annualised). The board re-appointed Chandra Wadhwa, Lata Pillai and Venkatesan Narayanan as Independent Directors for a second five-year term, subject to shareholder approval at the AGM, effective from 15 February 2027 and 15 March 2027. The board appointed M/s. Goyal, Goyal & Associates as Cost Auditor for FY 2026-27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 21 May 2026 | transcript Acquisition, Capex, Guidance, Results | Signatureglobal (India) Limited has informed the Exchange about TranscriptAI summarySignatureglobal (India) filed the transcript of its Q4 FY26 results investor/analyst call held on 14 May 2026. Management said FY26 profit reached an all-time high, with net debt brought down to near zero (about INR 2 billion); presales were INR 82.5 billion, with a dip versus FY25 but growth over FY22-FY26. Management reported revenue recognition of about INR 26 billion, a PAT of about INR 1,100-plus crore including an exceptional item from the RMZ transaction, and operating cash flow of about INR 21 billion. For FY27, management guided to new launches above INR 150 billion, sales above INR 100 billion, revenue recognition of INR 50 billion and collections above INR 50 billion. Management said the RMZ-partnered 5.5 million sq ft commercial project in Sector 71 is expected to be activated within the year, with a capital value above INR 150 billion once developed. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 May 2026 | presentation Acquisition, Capex, Guidance, Rating, Results | Signatureglobal (India) Limited has informed the Exchange about Investor PresentationAI summaryInvestor presentation for FY26 filed ahead of the investor/analyst call on 14 May 2026, 11:00 AM IST. FY26 sales INR 82.5 bn vs INR 102.9 bn in FY25; Q4 FY26 sales INR 15.7 bn vs INR 16.2 bn in Q4 FY25. FY26 collections INR 40.1 bn vs INR 43.8 bn in FY25. Average sales realization c. INR 15,250 per sqft in FY26 vs c. INR 12,457 per sqft in FY25; company reports net debt of INR 2.0 bn as of 31 March 2026. Management guidance for FY27: collections expected to grow 25%+ vs FY26, pre-sales targeted with 20%+ y-o-y growth, and launches planned in key micro markets. Pro forma FY27E shows pre-sales INR 100 bn, embedded EBITDA margin 35% and embedded PAT INR 24.7 bn (25% margin), versus FY26 pre-sales INR 82.5 bn and embedded PAT INR 21.0 bn. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 13 May 2026 | board outcome Legal, Management change, Results | Signatureglobal (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.AI summaryBoard outcome filed 13 May 2026: audited consolidated and standalone results for the quarter and year ended 31 March 2026 approved, with unmodified auditor opinions. Consolidated FY2026 revenue from operations Rs. 25,958.65 million versus Rs. 24,980.20 million in FY2025; consolidated net profit for the year Rs. 10,946.44 million versus Rs. 1,012.09 million, with an exceptional item of Rs. 12,672.19 million in the year (per the printed results). Consolidated Q4 FY2026 revenue from operations Rs. 11,072.66 million versus Rs. 5,204.33 million in Q4 FY2025; quarterly net profit Rs. 11,524.08 million. Board also approved appointment of Mr. Bharat Bhushan as Non-Executive Independent Director (additional director) for a first 5-year term from 13 May 2026, subject to member approval. Board approved appointment of M/s. S. N. Dhawan & Co LLP as Statutory Auditors for a first 5-year term from the 27th AGM to the 32nd AGM, subject to member approval, replacing Walker Chandiok & Co LLP whose second term expires at the ensuing AGM; and appointment of M/s. Jain Jindal & Co. as Internal Auditor for FY 2026-27. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 11 Feb 2026 | transcript Capex, Guidance, Results | Signatureglobal (India) Limited has informed the Exchange about TranscriptAI summarySignatureglobal (India) Limited filed the transcript of its Q3 FY26 earnings conference call held on 4 February 2026. Management said 9-month FY26 adjusted gross profit margin was 31% and Q3 FY26 margin was 40%; launches over 9 months were about 6.8 million sq ft (GDV upwards of INR104 billion), with launches expected to exceed INR150 billion against an initial guidance of about INR170 billion. Management reported Q3 sales of INR20.1 billion, a 9-month sales average closer to INR67 billion, and collections of about INR12.3 billion in the quarter; net debt was in the INR10 billion range. Management said it is confident net debt will come down to zero within calendar 2026 and expects a significant narrowing of the gap to annual guidance by year end. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Feb 2026 | presentation Guidance, Rating, Results | Signatureglobal (India) Limited has informed the Exchange about Investor PresentationAI summaryCompany filed its 9M'FY26 investor presentation ahead of an investors/analysts call on 4 February 2026 at 11:00 A.M. (IST). Sales bookings were INR 20.2 bn in Q3'FY26 versus INR 27.7 bn in Q3'FY25, and INR 66.8 bn in 9M'FY26 versus INR 86.7 bn in 9M'FY25; management said muted pre-sales reflect the overall market turning softer. Collections were INR 12.3 bn in Q3'FY26 versus INR 10.8 bn in Q3'FY25, and INR 30.9 bn in 9M'FY26 versus INR 32.1 bn in 9M'FY25; operating cash surplus before land investment was INR 8.6 bn in 9M'FY26. Net debt stood at INR 10.2 bn as of 31 December 2025, and CARE rated the NCD issuance A+ (stable). FY26 guidance: pre-sales INR 125 bn, launches INR 170 bn, collections INR 60 bn and revenue recognition INR 48 bn, with embedded EBITDA of INR 43.8 bn (35%) and embedded PAT of INR 31.0 bn (25%) on pro forma basis. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 03 Feb 2026 | board outcome Legal, Results | Signatureglobal (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.AI summaryBoard of Signatureglobal (India) Limited approved unaudited consolidated and standalone financial results for the quarter and nine months ended 31 December 2025 at a meeting held on 3 February 2026. Consolidated net loss for the quarter ended 31 December 2025 was Rs. 453.38 million, against a net profit of Rs. 291.35 million in the quarter ended 31 December 2024; revenue from operations was Rs. 2,844.38 million. Consolidated net loss for the nine months ended 31 December 2025 was Rs. 577.64 million, against a net profit of Rs. 400.83 million a year earlier; revenue from operations was Rs. 14,885.99 million. The filing also enclosed the NCD issue proceeds utilisation statement, the deviation statement and a security cover certificate as at 31 December 2025, with the minimum security cover requirement stated as 1.50x. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Nov 2025 | transcript Acquisition, Capex, Dividend / buy-back, Guidance, Rating, Results | Signatureglobal (India) Limited has informed the Exchange about TranscriptAI summarySignatureglobal (India) filed the transcript of its Q2 FY26 earnings conference call held on 10 November 2025. Management said H1 FY26 sales were about INR46.6 billion (about 3 million sq ft at about INR15,700 per sq ft, 1,338 units), a little short of 40% of the FY26 sales guidance of about INR125 billion. Management said H1 FY26 revenue recognition was about INR12 billion, with gross profit margin of about 29%, and that EBITDA margin dipped due to lower-than-anticipated revenue recognition. Management reiterated FY26 guidance of launches of INR170 billion, sales of INR125 billion, collections of INR60 billion and revenue recognition of INR48 billion. Management said it raised INR8.75 billion (almost $100 million) via private placement of NCDs to IFC, and that CARE rated it A+ stable; net debt was about INR9.7 billion. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 Nov 2025 | presentation Capex, Guidance, Rating, Results | Signatureglobal (India) Limited has informed the Exchange about Investor PresentationAI summaryInvestor presentation for H1 FY26 (November 2025) filed ahead of the investors/analysts call on 10 November 2025 at 12:30 PM IST. Sales bookings were INR 46.6 bn in H1 FY26 versus INR 59.0 bn in H1 FY25; Q2 FY26 sales were INR 20.2 bn versus INR 27.8 bn in Q2 FY25. Management said it is on track to meet FY26 pre-sales guidance of INR 125 bn. Collections were INR 18.6 bn in H1 FY26 versus INR 21.3 bn in H1 FY25, with operating cash surplus before land investment of INR 4.0 bn in H1 FY26. Net debt stood at INR 9.7 bn as of 30 September 2025; CARE has rated the non-convertible debenture issuance A+ (stable). Company added about 2.3 mn sqft of portfolio in the Sohna region during H1 FY26; management expects around 75% of full-year launches in H2. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 Nov 2025 | board outcome Results | Signatureglobal (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.AI summarySignatureGlobal (India) Limited filed the outcome of its board meeting held on 7 November 2025, approving unaudited consolidated and standalone financial results for the quarter and half year ended 30 September 2025, with limited review reports from statutory auditors. Consolidated revenue from operations for the quarter ended 30 September 2025 was Rs 3,384.92 million, against Rs 8,656.69 million in the quarter ended 30 June 2025 and Rs 7,492.88 million in the corresponding quarter a year earlier (as printed in the statement). Consolidated net loss for the quarter ended 30 September 2025 was Rs 468.61 million, versus a profit of Rs 344.19 million in the quarter ended 30 June 2025; for the six months ended 30 September 2025, net loss was Rs 124.26 million. Basic loss per share for the quarter ended 30 September 2025 was Rs 3.34 (face value Rs 1 per share). The filing states that Regulation 52(7), 52(7A), 54 and 56 disclosures are not applicable for the period, as the non-convertible debentures were listed after the end of the September 2025 quarter. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 14 Aug 2025 | transcript Capex, Dividend / buy-back, Guidance, Rating, Results | Signatureglobal (India) Limited has informed the Exchange about TranscriptAI summarySignatureglobal (India) filed the transcript of its Q1 FY26 earnings conference call held on 8 August 2025. Chairman Pradeep Kumar Aggarwal said revenue doubled and profit rose manyfold in Q1 FY26, and the company is confident of reaching FY26 guidance of INR125 billion presales and INR48 billion revenue recognition. CEO Rajat Kathuria said about 2 million sq ft of new projects were launched with GDV of about INR4,000 crores, including Cloverdale, and presales were about INR2,600-plus crores during the quarter. Management reported revenue recognition of about INR8.7 billion from 1.44 million sq ft of completions, with gross margin of about 27%, EBITDA margin of about 11% and PAT margin of about 4%. Management said it plans listed non-convertible debentures, for which CARE has assigned an A+ rating, and that incremental construction debt is being raised at about 9% to 9.5%. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 Aug 2025 | presentation | Signatureglobal (India) Limited has informed the Exchange about Investor Presentation | NSE copy |
| 07 Aug 2025 | board outcome Legal, Management change, Results | Signatureglobal (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.AI summaryBoard approved unaudited consolidated and standalone financial results for the quarter ended 30 June 2025 (board meeting held 7 August 2025). Consolidated revenue from operations for Q1 FY26 was Rs. 8,656.69 million, against Rs. 5,204.33 million in the preceding quarter and Rs. 4,006.14 million in the year-ago quarter. Consolidated net profit for the quarter was Rs. 344.35 million, against Rs. 611.26 million in the preceding quarter and Rs. 67.96 million in the year-ago quarter. Consolidated basic EPS for the quarter was Rs. 2.45 (face value Rs. 1 per share). Board also approved re-appointment of Mr. Kundan Mal Agarwal as Independent Director for a second five-year term from 2 April 2026, subject to shareholder approval, and appointment of Deepak Sharma & Associates as Secretarial Auditor for FY2025-26 to FY2029-30, Goyal, Goyal & Associates as Cost Auditor and Jain Jindal & Co. as Internal Auditor for FY2025-26. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 01 Aug 2025 | credit rating Capex, Rating | Signatureglobal (India) Limited has informed the Exchange about Credit Rating- NewAI summarySignatureglobal (India) Limited filed an intimation under Regulation 30 of the SEBI LODR Regulations, 2015, dated 1 August 2025. CARE Ratings Limited, via its communication dated 31 July 2025, assigned CARE A+; Stable to proposed Long-term Non-Convertible Debentures issue aggregating Rs. 875 crore. The rated NCDs comprise Rs. 865.00 crore and Rs. 10.00 crore tranches, both with outlook Stable. The proposed NCDs would have a tenure of 3.5 years with repayment in 12 quarterly installments. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 25 Jun 2025 | board outcome Acquisition, Capex, Legal | Signatureglobal (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 25, 2025.AI summaryBoard of SignatureGlobal (India) Limited, meeting held on 25 June 2025, approved raising funds through issuance of Secured Listed Redeemable Non-Convertible Debentures on private placement basis, for an amount not exceeding Rs. 8,75,00,00,000 (Rs. 875 crore), in one or more series/tranches, subject to necessary approvals. The Board constituted a Debenture Committee and delegated to it powers for issuance and allotment of the NCDs. The Board approved an amendment to the Articles of Association, subject to shareholder approval, to insert a clause on appointment of a director nominated by the Debenture Trustee(s). The Board approved a Notice of Postal Ballot seeking shareholder approval for NCD issuance, enhancement of borrowing limit, enhancement of limit for creation of security, and alteration of Articles of Association. The trading window, already closed, remains closed till Friday, 27 June 2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 22 May 2025 | transcript Dividend / buy-back, Guidance, Results | Signatureglobal (India) Limited has informed the Exchange about TranscriptAI summarySignatureglobal (India) Limited filed the transcript of its Q4 FY25 investor/analyst earnings call held on 16 May 2025. Management reported FY25 presales of INR102.9 billion (up 42% YoY), record collections of INR43.8 billion (up 41%), and revenue from operations of INR25 billion versus INR12.41 billion in FY24. Management reported PAT of INR1.01 billion for FY25 (4.1% margin versus 1.3%), net debt of INR8.8 billion at FY25 end versus INR11.6 billion in FY24, and an adjusted gross margin of 31%. Management guided to presales above INR12,500 crores in FY26 (more than 20% growth), collections of INR60 billion (about 35% growth), and fresh launches above INR170 billion. Management said it targets 20%-plus presales growth over the medium term and that net debt to operating cash flow will not exceed 0.5x. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 15 May 2025 | presentation Acquisition, Capex, Guidance, Results | Signatureglobal (India) Limited has informed the Exchange about Investor PresentationAI summaryInvestor presentation for FY25 filed ahead of the investor/analyst call on 16 May 2025 at 11:00 A.M. (IST). FY25 sales were INR 102.9 bn vs INR 72.7 bn in FY24 (42% growth); sales volume rose 34% to 8.3 mn sqft; collections were INR 43.8 bn (41% growth); operating surplus before land investment was INR 16.3 bn. Management guided FY26 launches of INR 170 bn, pre-sales of INR 125 bn, collections of INR 60 bn and revenue recognition of INR 48 bn. Management said it added c. 7.9 mn sqft of land in FY25 and aims to deliver ongoing projects in the coming 7-8 quarters. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 15 May 2025 | board outcome Acquisition, Management change, Results | Signatureglobal (India) Limited has informed the Exchange regarding Outcome of Board Meeting held on May 15, 2025.AI summarySIGNATUREGLOBAL (India) Limited filed the outcome of its board meeting held on 15 May 2025, approving audited consolidated and standalone results for the quarter and year ended 31 March 2025, with unmodified auditor opinions. Consolidated revenue from operations for the year ended 31 March 2025 was Rs. 24,980.20 million, against Rs. 12,405.54 million a year earlier; consolidated net profit for the year was Rs. 1,012.09 million, against Rs. 163.24 million. For the quarter ended 31 March 2025, consolidated revenue from operations was Rs. 5,204.33 million and net profit was Rs. 611.26 million. The board approved the appointment of senior management personnel with effect from 15 May 2025. The board decided to acquire the balance 4,15,600 equity shares (15.41%) of subsidiary Indeed Fincap Private Limited for a consideration not exceeding Rs. 2.826 crore, after which Indeed becomes a wholly owned subsidiary. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 17 Feb 2025 | transcript Guidance, Results | Signatureglobal (India) Limited has informed the Exchange about TranscriptAI summarySignatureglobal (India) Limited filed the transcript of its Q3 FY25 earnings conference call held on 11 February 2025. Management said 9M FY25 pre-sales were INR 86.7 billion, up 178% year-on-year, and Q3 pre-sales were INR 27.7 billion; trailing 12-month (CY2024) pre-sales were INR 128.8 billion. Management said it is keeping FY25 guidance constant at collections of INR 60 billion and revenue recognition of INR 38 billion, and expects to comfortably surpass INR 100 billion of pre-sales. Management said 9M FY25 collections exceeded INR 32 billion and operating surplus after tax was about 38% of collections, with net debt guided to stay below 0.5x annualised operating surplus. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Feb 2025 | results Acquisition, Management change, Results | Integrated Filing (Financials) for the quarter ended 31st December, 2024.AI summaryIntegrated filing (financial) for the quarter and nine months ended 31 December 2024, submitted under SEBI circular dated 31 December 2024, with unaudited consolidated results approved by the Board on 10 February 2025. Quarter ended 31 December 2024: total income Rs. 8,621.47 million, net profit Rs. 291.35 million (quarter ended 30 September 2024: Rs. 41.52 million; quarter ended 31 December 2023: Rs. 21.79 million). Nine months ended 31 December 2024: revenue from operations Rs. 19,775.87 million, net profit Rs. 400.83 million (nine months ended 31 December 2023: loss of Rs. 249.30 million). Basic and diluted EPS for the quarter ended 31 December 2024 were Rs. 2.07 per share (face value Rs. 1). A sale deed for a Gurugram land parcel was executed on 10 January 2025, terminating the related joint development agreement; a Chief Financial Officer was also appointed after the quarter. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Feb 2025 | presentation Guidance, Results | Signatureglobal (India) Limited has informed the Exchange about Investor PresentationAI summaryInvestor presentation for the 9M FY25 investor/analyst call scheduled for 11 February 2025 at 11:00 AM IST, filed under Regulation 30 of SEBI LODR. Sales bookings were INR 27.7 bn in Q3 FY25 (vs INR 12.6 bn in Q3 FY24, up 120%) and INR 86.7 bn in 9M FY25 (vs INR 31.2 bn in 9M FY24, up 178%), with management stating c.87% of FY25 sales guidance achieved. Collections were INR 10.8 bn in Q3 FY25 (up 40% YoY) and INR 32.1 bn in 9M FY25 (up 54% YoY), with c.53% of FY25 collection guidance achieved. Average sales realization was c.INR 12,565 per sq ft for 9M FY25 vs c.INR 11,762 per sq ft in FY24; Q3 FY25 realization was INR 11,124 per sq ft. Management said the company sold more than 3,500 units at an average ticket size of INR 25.0 Mn in 9M FY25 and reported trailing 12-month pre-sales of INR 128.2 bn. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Feb 2025 | board outcome Management change, Results | Signatureglobal (India) Limited has informed the Exchange regarding Board meeting held on February 10, 2025.AI summarySignatureglobal (India) Limited filed the outcome of its board meeting held on 10 February 2025, approving unaudited consolidated and standalone financial results for the quarter and nine months ended 31 December 2024. Consolidated revenue from operations for the quarter ended 31 December 2024 was Rs. 8,276.85 million, against Rs. 2,818.05 million in the corresponding quarter of the previous year; net profit attributable to owners was Rs. 291.16 million (Rs. 21.31 million a year earlier). Consolidated revenue from operations for the nine months ended 31 December 2024 was Rs. 19,775.87 million; consolidated net profit attributable to owners was Rs. 399.88 million. The board also approved re-appointment of M/s Deepak Sharma & Associates as Secretarial Auditors for FY 2024-25 and issued a press release on the results. The filing notes that Mr. Sanjeev Kumar Sharma was appointed Chief Financial Officer and Key Managerial Personnel with effect from 7 January 2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 10 Feb 2025 | results Legal, Management change, Results | Signatureglobal (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.AI summarySignatureglobal (India) Limited filed the outcome of its board meeting held on 10 February 2025, approving unaudited consolidated and standalone results for the quarter and nine months ended 31 December 2024. Consolidated revenue from operations for the quarter ended 31 December 2024 was Rs. 8,276.85 million, against Rs. 2,818.05 million a year earlier; net profit attributable to owners was Rs. 291.16 million (Rs. 21.31 million a year earlier). Consolidated revenue from operations for the nine months ended 31 December 2024 was Rs. 19,775.87 million; basic and diluted EPS for the nine months was Rs. 2.85. The board also approved re-appointment of M/s Deepak Sharma & Associates as Secretarial Auditors for FY 2024-25. The notes state Mr. Sanjeev Kumar Sharma was appointed Chief Financial Officer and KMP with effect from 7 January 2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
| 07 Jan 2025 | board outcome Management change | Outcome of Board Meeting - Appointment of CFO & Senior Management Personnel(s)AI summarySignatureglobal (India) Limited filed the outcome of its board meeting held on 7 January 2025, which ran from 15:08 to 15:32 hours. The board appointed Mr. Sanjeev Kumar Sharma as Chief Financial Officer and Key Managerial Personnel, effective 7 January 2025. The board revised the authority for determining materiality of events and making disclosures under Regulation 30(5), naming Mr. Ravi Aggarwal (Managing Director), Mr. Rajat Kathuria (CEO), Mr. M R Bothra (Company Secretary) and Mr. Sanjeev Kumar Sharma (CFO). The board approved the appointment of senior management personnel, including Mr. Sapan Bebarta as President – Legal and Mr. Sapan Madan as Vice President – Sales, effective 7 January 2025. Written by an AI model (claude-haiku-5-5) from the filing's first pages; it can be wrong - the filing is the source. | NSE copy |
The list of announcements the National Stock Exchange publishes for the company; each link opens the exchange's own copy. Ask Sensei searches these filings when a question names the company.